| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
 |
|
Site Navigation
| ALS News & Research For postings of news or research links and articles related to ALS |
advertisement
| Reply |
|
|
Thread Tools | Display Modes |
|
|
| ALS News & Research For postings of news or research links and articles related to ALS |
| Reply |
|
|
Thread Tools | Display Modes |
10-30-2019, 10:34 AM
|
#1 | |||
|
||||
|
Grand Magnate
|
First ALS Patient Enters US Study of Radicava's Impact on Disease Biomarkers
First ALS Patient Enters US Study of Radicava's Impact on Disease Biomarkers If I understand the medical argument underlying the Radicava strategy, the hypothesis is patients with the Amyotrophic Lateral Sclerosis syndrome may have suffered small stroke in their life without realization. Radicava is know to have positive effects in stroke patients . . . these positive effects might have collateral benefit(s) in Amyotrophic Lateral Sclerosis patients . . . possibly only because they indeed had stroke(s). |
|||
|
 Reply With Quote
|
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Parki | Parkinson's Disease | |||
| video - NINDS Parkinson’s Disease Biomarkers Program Enrolls 1,000th Patient | Parkinson's Disease | |||
| Biomarkers in Parkinson’s disease (recent update) | Parkinson's Disease | |||
| PRE-CLINICAL STUDY: Implant patient's own retinal cells to treat Parkinson's disease | Parkinson's Disease Clinical Trials | |||
First ALS Patient Enters US Study of Radicava's Impact on Disease Biomarkers
Linear Mode
